Polyplus-transfection® SA holds a strong portfolio of patents and patent applications. Our Research and Development focuses on the development of innovative and efficient solutions for the delivery of nucleic acids in research, bioproduction and therapeutics. Our ambition is to keep our nucleic acid delivery technologies at the forefront of the battle to understand, treat and prevent cancer, as well as other infectious, immunologic and allergic diseases.
Polyplus-transfection® SA also holds a portfolio of trademarks.
For licensing or partnering opportunities in the fields of Nucleic-Acid-Based Therapy, Molecular Biology or Diagnostics, please visit our webpage dedicated to Licensing Opportunities.
STICKY SIRNAs are the subject matter of US Patent No. 8,802,640, US divisional patent application no. 14/321086, European Patent No. 1 888 749 and foreign equivalents entitled “Oligonucleotides for RNA interference and biological applications thereof”.
OLIGOPLUS and SIRNAPLUS®
OLIGOPLUS and Spermine Phosphoramidite are the subject matter of U.S. Patent No. 9090648, European Patent No. 1 973 927 and foreign equivalents entitled “Cationic oligonucleotides, automated methods for preparing same and their uses”.
SIRNAPLUS® are the subject matter of Patent Application WO/2009/095887 entitled “Cationic siRNAs, synthesis and use for RNA interference”.
Zip Nucleic Acids (ZNA®) and Spermine phosphoramidite
ZNA®, Spermine phosphoramidite and their use are the subject matter of (i) U.S. Patent No. 9090648, U.S. Divisional Patent Application No. 14/745,871, European Patent No. 1 973 927 and foreign equivalents entitled “Cationic oligonucleotides, automated methods for preparing same and their uses” and (ii) U.S. Patent No. 8,465,920, European Patent No. 2 225 393 and foreign equivalents entitled “Methods for hybridizing nucleic acids”.
The purchase of ZNA® oligonucleotides or Spermine Phosphoramidite does not include or carry an implied right or license for the buyer to use such products for commercial purposes. A license must be obtained directly from Polyplus-transfection for commercial use of these products, including but not limited to use in diagnostic procedures. For a commercial license to the ZNA® Intellectual Property, please visit our webpage dedicated to Licensing Opportunities and feel free to contact us.
The use of certain transfection reagents sold by Polyplus-transfection® are the subject of proprietary patents or patent applications.
The buyer agrees not to infringe upon Polyplus-transfection® patents or to attempt to reverse engineer, reconstruct, synthesize or otherwise modify Polyplus-transfection® products.
These products, or parts from these products, may not be re-packaged or re-sold without written agreement from Polyplus-transfection®.
Registered names, trademarks, etc. used in the Polyplus-transfection® website, even when not specifically marked as such, are not to be considered unprotected by law.